p Ketan Garg, MD - VMMC and SJH - Dr

p Ketan Garg

MD

VMMC and SJH

Dr

NEW DELHI, DELHI | India

Main Specialties: Blood Banking - Transfusion Medicine, Clinical & Laboratory Immunology, Dermatopathology, Hematology, Hematology & Oncology, Medical Microbiology, Pathology-Anatomic & Clinical

Additional Specialties: Pathology, hematology

ORCID logohttps://orcid.org/0000-0003-3247-7463

p Ketan Garg, MD - VMMC and SJH - Dr

p Ketan Garg

MD

Introduction

As a medical professional, after completing MD, I have been running my own pathology Lab for the last 4 years. Recently it has been NABL accredited and has come under various panels. I developed interest in the documentation and medical writing, so have started assisting NABL/NABH certifications for other medical professionals.

Primary Affiliation: VMMC and SJH - NEW DELHI, DELHI , India

Specialties:

Additional Specialties:

Research Interests:


View p Ketan Garg’s Resume / CV

Education

May 2013
VMMC and SJH
MD
Gold medalist

Experience

Aug 2016
Kegan pathlabs
Consultant
NABL accredited and internal auditor

Publications

6Publications

70Reads

70Profile Views

2PubMed Central Citations

Seroprevalence of transfusion-transmissible infections among replacement and voluntary blood donors in a tertiary care hospital.

Indian J Sex Transm Dis AIDS 2017 Jan-Jun;38(1):101-102

Department of Pathology, Safdarjung Hospital, New Delhi, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0253-7184.203442DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389209PMC
April 2017
12 Reads

Choroid plexus papilloma.

Asian J Neurosurg 2017 Jan-Mar;12(1):139-141

Department of Pathology, VMMC and Safdarjang Hospital, New Delhi, India.

View Article

Download full-text PDF

Source
http://www.asianjns.org/text.asp?2017/12/1/139/153501
Publisher Site
http://dx.doi.org/10.4103/1793-5482.153501DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379790PMC
April 2017
12 Reads

A Retrospective Analysis of Apheresis Donor Deferral and Adverse Reactions at a Tertiary Care Centre in India.

J Clin Diagn Res 2016 Nov 1;10(11):EC22-EC24. Epub 2016 Nov 1.

Professor and Head, Department of Pathology, Safdarjung Hospital , Delhi, India .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7860/JCDR/2016/20707.8925DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198329PMC
November 2016
7 Reads

Single organ variant of polyarteritis nodosa in epididymis.

J Cancer Res Ther 2015 Jul-Sep;11(3):662

Department of Pathology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0973-1482.138133DOI Listing
August 2016
3 Reads

Estimation of tumor volume and its prognostic significance to study the biological behavior of carcinoma of cervix

Dawson L, Garg K, Choudhary S. Estimation of tumor volume and its prognostic significance to study the biological behavior of carcinoma of cervix. Asian J Oncol 2016;2:35-42

Asian Journal of Oncology

Objective: The objective of this study was to assess a correlation between tumor volume, the spread and metastatic potential of the tumor. Materials and Methods: A prospective study was done on 40 cases of carcinoma of cervix with stage IIb or less. The hysterectomy specimens alongwith the lymph nodes were sent to the histopathology department. Clinical details were taken from gynecology department. Hematoxylin and eosin slides were prepared and seen. Tumor volume was calculated by using the formula TV = π/6×Length×Width×Depth. Immunohistochemistry for Fibronectin and LN5 was also done. Results: The median age of the patients in this group was 47.5 years, with a range of 30–80 years. The major histological type of carcinoma among 40 cases is squamous cell carcinoma (SCC) (in 90% of cases), and 10% had adenocarcinoma. Pathological staging of the carcinoma cervix showed stage Ib, IIa, IIb, and IVa (35%, 20%, 40%, and 5%). Tumor volume estimated on pathological specimens of 40 cases ranged from 230 cumm to 49,760 cumm with a mean of 14,844 cumm. 12 (30%) cases had tumor volume more than 15,000 cumm, 12 (30%) cases had tumor volume <5000 cumm and 16 (40%) cases had tumor volume between 5000 and 15,000 cumm. 17% of the tumors with tumor volume <5000 cumm showed lymph node metastases, whereas 67% (out of 12cases) of cases with tumor volume more than 15,000 cumm showed lymph node metastases. 67% of the tumors with tumor volume <5000 cumm showed 0/4 organs involvement, whereas all cases with tumor volume more than 15,000 cumm showed more than one organ involvement among vagina, uterus, parametrium or bladder/rectum. Fibronectin positivity was seen in 22 out of 44 cases (55%). Macrophages were seen surrounding the group of tumor cells by LN5 immunostaining. Conclusion: Tumor volume can be considered as an independent prognostic factor to assess the spread of the tumor. Cases with tumor volume <5000 cumm show low risk in terms of parametrial involvement and lymph node metastasis and those with tumor volume more than 15,000 cumm showed more organ spread. Fibronectin positivity carries some importance in low-risk cases. For macrophages, further detailed study needs to be carried out.

View Article
April 2016
1 Read

Malignant fibrous histiocytoma of the spleen: an extremely rare entity.

J Cancer Res Ther 2012 Jan-Mar;8(1):117-9

Department of Pathology, VMMC and Safdarjung Hospital, New Delhi, India.

View Article

Download full-text PDF

Source
http://www.cancerjournal.net/text.asp?2012/8/1/117/95188
Publisher Site
http://dx.doi.org/10.4103/0973-1482.95188DOI Listing
August 2012
36 Reads
2 Citations